Sign up free

Thomas K. Equels

Thomas K. Equels has made 6 open-market purchases worth $24k since Sep 15, 2026, in 1 company. The latest: $5k of AIM, filed Oct 26, 2026, scored 40 out of 100.

CEO, AIM ImmunoTech Inc.

Follow Thomas K. Equels, freeOpen the live feed

A free account gets an alert the minute a new buy or sale is filed.

$24kbought, 6 purchases
$0sold, 0 sales
1company bought
—kind of buyer, by the latest buy

Purchases

FiledStockStakeScoreBought1 week1 month
Oct 26
Form 4 (opens sec.gov)
AIMAIM ImmunoTech Inc. · CEOCEO · Near 52-week low · Penny stock: hard to trade +20% stake 40 $5k
31,675 at $0.16
——
Oct 23
Form 4 (opens sec.gov)
AIMAIM ImmunoTech Inc. · CEOCEO · Near 52-week low · Penny stock: hard to trade +25% stake 40 $5k
31,250 at $0.16
——
Sep 18
Form 4 (opens sec.gov)
AIMAIM ImmunoTech Inc. · CEOCEO · Near 52-week low · Penny stock: hard to trade +23% stake 40 $5k
24,000 at $0.21
——
Sep 17
Form 4 (opens sec.gov)
AIMAIM ImmunoTech Inc. · CEOCEO · Near 52-week low · Penny stock: hard to trade +12% stake 35 $2k
11,000 at $0.21
——
Sep 16
Form 4 (opens sec.gov)
AIMAIM ImmunoTech Inc. · CEOCEO · Near 52-week low · Penny stock: hard to trade +32% stake 40 $5k
22,000 at $0.22
——
Sep 15
Form 4 (opens sec.gov)
AIMAIM ImmunoTech Inc. · CEOCEO · Near 52-week low · Penny stock: hard to trade +9% stake 30 $1k
5,900 at $0.22
——

Questions

What stock has Thomas K. Equels bought?

AIM (AIM ImmunoTech Inc.), all on the open market and reported on SEC Form 4.

When did Thomas K. Equels last buy?

Oct 26, 2026: 31,675 shares of AIM at $0.16, $5k in all (Form 4 (opens sec.gov)).

Has Thomas K. Equels filed a notice of a planned sale?

Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.

Is Thomas K. Equels a routine or an opportunistic buyer?

There isn't enough history to say yet.

Data as of Oct 26, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer

Follow insiders. Sell when they sell.Free in early access, no card

Sign up free